Financial News · Live Terminal

Page 35 of 299

BNP Paribas Upgrades Bunzl to Outperform, Boosts PT

BNP Paribas on Tuesday upgraded British distribution and outsourcing group Bunzl (BNZL.L) to outperform from neutral and raised its price target to 30.00 pounds sterling from 24.50 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Financial News · Live Terminal

BNP Paribas Upgrades Bunzl to Outperform, Boosts PT

Morgan Stanley Reduces Advanced Petrochemical's PT, Affirms at Underweight

Kepler Cheuvreux Upgrades Bper Banca to Buy, Lifts PT

BNP Paribas Downgrades Tate & Lyle to Neutral Rating

AlphaValue/Baader Europe Upgrades Yara International to Add, Lifts PT

Wood & Co. Downgrades Erste Bank Polska to Hold, Trims PT

Morningstar Upgrades Marks and Spencer to Buy, Boosts PT

Morgan Stanley Reduces Campari Group PT, Keeps at Equalweight

EFG-Hermes Brokerage Lifts Gas Arabian Services PT, Keeps at Buy

Shore Capital Downgrades Oxford Instruments to Hold, Boosts PT

Cantor Fitzgerald Downgrades Nuvalent to Neutral From Overweight

Wedbush Downgrades Nuvalent to Neutral From Outperform, Trims Price Target to $124 From $125

Piper Sandler Downgrades Nuvalent to Neutral From Overweight, Adjusts PT to $124 From $128

Argus Research Downgrades Prudential Financial to Hold From Buy

B. Riley Raises Price Target on Tango Therapeutics to $35 From $21, Keeps Buy Rating

CN Rail Price Target Raised to $182 at CIBC

B. Riley Initiates NioCorp Developments at Buy With $12 Price Target

Keefe Bruyette & Woods Upgrades Toll Brothers to Outperform From Market Perform, Lifts Price Target to $161 From $158

Citigroup Upgrades PTC Therapeutics to Buy From Hold, Raise Price Target to $108 From $76

JPMorgan Upgrades PAR Technology to Neutral From Underweight, Lifts Price Target to $16 From $12

BNP Paribas Upgrades Bunzl to Outperform, Boosts PT

Morgan Stanley Reduces Advanced Petrochemical's PT, Affirms at Underweight

Kepler Cheuvreux Upgrades Bper Banca to Buy, Lifts PT

BNP Paribas Downgrades Tate & Lyle to Neutral Rating

AlphaValue/Baader Europe Upgrades Yara International to Add, Lifts PT

Wood & Co. Downgrades Erste Bank Polska to Hold, Trims PT

Morningstar Upgrades Marks and Spencer to Buy, Boosts PT

Morgan Stanley Reduces Campari Group PT, Keeps at Equalweight

EFG-Hermes Brokerage Lifts Gas Arabian Services PT, Keeps at Buy

Shore Capital Downgrades Oxford Instruments to Hold, Boosts PT

Cantor Fitzgerald Downgrades Nuvalent to Neutral From Overweight

Wedbush Downgrades Nuvalent to Neutral From Outperform, Trims Price Target to $124 From $125

Piper Sandler Downgrades Nuvalent to Neutral From Overweight, Adjusts PT to $124 From $128

Argus Research Downgrades Prudential Financial to Hold From Buy

B. Riley Raises Price Target on Tango Therapeutics to $35 From $21, Keeps Buy Rating

CN Rail Price Target Raised to $182 at CIBC

B. Riley Initiates NioCorp Developments at Buy With $12 Price Target

Keefe Bruyette & Woods Upgrades Toll Brothers to Outperform From Market Perform, Lifts Price Target to $161 From $158

Citigroup Upgrades PTC Therapeutics to Buy From Hold, Raise Price Target to $108 From $76

JPMorgan Upgrades PAR Technology to Neutral From Underweight, Lifts Price Target to $16 From $12